by Vandana Singh | Jun 24, 2026 | General
Spyre Therapeutics Inc. (NASDAQ:SYRE) stock plunged more than 12% on Wednesday as investors reacted to large insider stock sales. The stock is up more than 160% year to date and over 450% over the past year. Insider Sales Weigh on Sentiment Fairmount Healthcare Fund...
by Benzinga Insights | Jun 24, 2026 | General
On Wednesday, AGF Management (TSX:AGF) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit...
by Benzinga Insights | Jun 24, 2026 | General
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 4.21% on an annualized basis producing an average annual return of 15.79%. Currently, AbbVie has a market capitalization of $417.60 billion. Buying $100 In ABBV: If an investor had bought $100 of...
by Chandrima Sanyal | Jun 24, 2026 | General
The race between crypto exchange-traded products (ETP) and traditional growth-focused ETFs is turning increasingly one-sided, according to a new mid-year report from crypto asset manager 21Shares. While institutional adoption of digital assets continues to advance,...
by Akanksha Bakshi | Jun 24, 2026 | General
Xiao-I Corp. (NASDAQ:AIXI) stock fell Wednesday amid challenges in its ongoing patent litigation against Apple Inc. (NASDAQ:AAPL). Xiao-I To Appeal Apple Patent Case After Shanghai Court Rulings On Friday, Xiao-I said it will appeal to China’s Supreme People’s Court...
Recent Comments